Registry study of chronic low parathyroid function in France
Part of Hormones & metabolism clinical trials.
This is a registry (data collection) study that gathers information about people diagnosed with chronic hypoparathyroidism in France. It helps researchers better understand how common it is and what it looks like in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic hypoparathyroidism (a long-term low-function parathyroid problem).
- You currently live in France.
- You are willing to let your health data be collected for this registry.
- Your condition is not “pseudo-hypoparathyroidism” (a look-alike condition that isn’t the same).
- Your condition is not acute hypoparathyroidism (a short-term form).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects health information from people with chronic low parathyroid hormone (hypoparathyroidism) or pseudohypoparathyroidism. It aims to better understand these conditions and improve future care. You may join if you are an adult living in Germany.
This trial is creating a registry (a database) for people with parathyroid disease. It will collect information to help doctors better understand and treat these conditions.
This study is creating a database of people with hypoparathyroidism or pseudohypoparathyroidism in Italy. It may help researchers learn more about these conditions and improve future care.
This study follows adults with hypoparathyroidism to better understand what symptoms and lab levels change over time. It may help doctors plan future treatments by learning the natural course of the condition, even if you already take standard medicines.
This study looks at how chronic hypoparathyroidism affects daily life and well-being. It may help understand the condition better and improve support for patients.
This study tests a new medicine called encaleret for people with chronic hypoparathyroidism, a condition where the body has too little parathyroid hormone, leading to low calcium levels. The medicine aims to improve calcium balance and reduce the need for daily calcium and vitamin D supplements.
Hear when a new Hypoparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.